Cited by 328Lipid metabolism and disordersLipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Apolipoprotein E isoforms and lipoprotein metabolism

Phillips, Michael C.·2014·IUBMB Life

Open this paper in CoChat — free account

Abstract

Apolipoprotein (apo) E is a 299‐residue protein which functions as a key regulator of plasma lipid levels. Human apoE exists as three common isoforms and the parent form, apoE3, operates optimally in promoting clearance of triglyceride (TG)‐rich lipoproteins and is associated with normal plasma lipid levels. This result occurs because apoE3 possesses both the requisite lipid‐binding ability and affinity for the low density lipoprotein receptor (LDLR) to mediate appropriate lipolytic processing and endocytosis of TG‐rich lipoprotein remnant particles. ApoE2 which differs from apoE3 by the single amino acid substitution Arg158Cys located near the LDLR recognition site exhibits impaired binding to the receptor and an inability to promote clearance of TG‐rich lipoprotein remnant particles; this isoform is associated with Type‐III hyperlipoproteinemia. ApoE4 which differs from apoE3 by the single amino acid substitution Cys112Arg is also associated with dyslipidemia although binding of this isoform to the LDLR is unaffected. The amino acid substitution affects the organization and stability of both the N‐terminal helix bundle domain and separately folded C‐terminal domain so that apoE4 has enhanced lipid binding ability. As a consequence, apoE4 binds better than apoE3 to the surface of very low density lipoprotein (VLDL) particles and impairs their lipolytic processing in the circulation so that apoE4 is associated with a more pro‐atherogenic lipoprotein‐cholesterol distribution (higher VLDL‐cholesterol/high density lipoprotein‐cholesterol ratio). This review summarizes current understanding of the structural differences between apoE2, apoE3, and apoE4, and the molecular mechanisms responsible for the alterations in lipoprotein metabolism resulting from this polymorphism of apoE. Detailed knowledge of how expression of structurally distinct apoE variants modifies lipoprotein metabolism provides a basis for developing ways to manipulate the functionality of apoE in vivo. © 2014 IUBMB Life, 66(9):616–623, 2014

Integrity signals

Registry

Crossref · 10.1002/iub.1314

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function.
Segrest, J., Jones, M., Loof, H. D., Brouillette, C. G., Venkatachalapathi, Y. V., & Anantharamaiah, G. M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41536-6 · Cited by 868
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
Abnormal lipoprotein receptor‐binding activity of the human E apoprotein due to cysteine‐arginine interchange at a single site
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Apolipoprotein E structure: insights into function
Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.06.008 · Cited by 583 · cited 1×
“The latter interaction occurs in quasi-spherical apoE/dipalmitoyl phosphatidylcholine particles where the two apoE molecules adopt a horseshoe shape (7,26).”
Background
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800069-jlr200 · Cited by 580
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes
Mahley, R. W., Huang, Y., & Rall, S. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32417-2 · Cited by 447
Apo E structure determines VLDL clearance and atherosclerosis risk in mice
Knouff, C., Hinsdale, M. E., Mezdour, H., Altenburg, M. K., Watanabe, M., Quarfordt, S. H., Sullivan, P. M., & Maeda, N. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6172 · Cited by 324
Human apolipoprotein E: Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms
Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., & Agard, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31797-0 · Cited by 320

Show all 59 references

Sorted by citations

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., & Bu, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0228-7 · Cited by 1,425
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
An, S. J., Kim, T. J., & Yoon, B. W. (2017) · Journal of Stroke · doi:10.5853/jos.2016.00864 · Cited by 1,049
Lipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
Transcriptional signature in microglia associated with Aβ plaque phagocytosis
Grubman, A., Choo, X. Y., Chew, G., Ouyang, J. F., Sun, G., Croft, N. P., Rossello, F. J., Simmons, R., Buckberry, S., Landin, D. V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23111-1 · Cited by 357
APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
Husain, M. A., Laurent, B., & Plourde, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.630502 · Cited by 353
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
High-density lipoproteins, reverse cholesterol transport and atherogenesis
Pownall, H. J., Rosales, C., Gillard, B. K., & Gotto, A. M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00538-z · Cited by 266
Bioactivity of soy-based fermented foods: A review
Cao, Z.-H., Green-Johnson, J. M., Buckley, N. D., & Lin, Q.-Y. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.12.001 · Cited by 231
Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
Zhao, N., Ren, Y., Yamazaki, Y., Qiao, W., Li, F., Felton, L. M., Mahmoudiandehkordi, S., Kueider-Paisley, A., Sonoustoun, B., Arnold, M., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.02.034 · Cited by 225
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
Mack, S., Coassin, S., Rueedi, R., Yousri, N. A., Seppälä, I., Gieger, C., Schönherr, S., Forer, L., Erhart, G., Marques-Vidal, P., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m076232 · Cited by 186
Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery
Kim, W., Ly, N. K., He, Y., Li, Y., Yuan, Z., & Yeo, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114635 · Cited by 176
APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective
Tai, L. M., Ghura, S., Koster, K. P., Liakaite, V., Maienschein‐Cline, M., Kanabar, P., Collins, N., Ben‐Aissa, M., Lei, A. Z., Bahroos, N., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13072 · Cited by 165
The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
Kloske, C. M., & Wilcock, D. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00754 · Cited by 152
Cholesterol metabolism: A review of how ageing disrupts the biological mechanisms responsible for its regulation
Morgan, A. E., Mooney, K. M., Wilkinson, S. J., Pickles, N. A., & Auley, M. T. M. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.008 · Cited by 145
A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions
Frieden, C., Wang, H., & Ho, C. M. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705080114 · Cited by 134
Apoprotein E and Reverse Cholesterol Transport
Getz, G. S., & Reardon, C. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113479 · Cited by 120
Re‐imagining Alzheimer's disease – the diminishing importance of amyloid and a glimpse of what lies ahead
Tse, K., & Herrup, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14079 · Cited by 107
Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease
Calderón‐Garcidueñas, L., Franco-Lira, M., D’Angiulli, A., Rodríguez-Díaz, J., Blaurock-Busch, E., Busch, Y. M., Chao, C., Thompson, C., Mukherjee, P. S., Torres‐Jardón, R., et al. (2015) · Environmental Research · doi:10.1016/j.envres.2015.05.012 · Cited by 107
Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients
Moriarty, P. M., Varvel, S. A., Gordts, P. L. S. M., McConnell, J. P., & Tsimikas, S. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308704 · Cited by 89
ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis
Getz, G. S., & Reardon, C. A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067249 · Cited by 90
Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels—Brief Report
Hoekstra, M., Chen, H. Y., Rong, J., Dufresne, L., Yao, J., Guo, X., Tsai, M. Y., Tsimikas, S., Post, W. S., Vasan, R. S., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314965 · Cited by 80
Genetic Markers of Alzheimer’s Disease
Perković, M. N., & Pivac, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_3 · Cited by 82
APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
Brandon, J. A., Farmer, B. C., Williams, H. C., & Johnson, L. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00180 · Cited by 75
Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice
Thomas, R., Zuchowska, P., Morris, A. W. J., Marottoli, F. M., Sunny, S., Deaton, R., Gann, P. H., & Tai, L. M. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0387-3 · Cited by 72
Lipids in Amyloid-β Processing, Aggregation, and Toxicity
Morgado, I., & Garvey, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_3 · Cited by 72
From degenerative disease to malignant tumors: Insight to the function of ApoE
Miao, G., Zhuo, D., Han, X. N., Yao, W., Liu, C., Liu, H., Cao, H., Sun, Y., Chen, Z., & Feng, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114127 · Cited by 76
Alzheimer’s Disease Risk Genes and Lipid Regulators
Gaamouch, F. E., Jing, P., Xia, J., & Cai, D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160169 · Cited by 67
Mitochondrial Metabolism in Major Neurological Diseases
Zhou, Z., Austin, G. L., Young, L. E. A., Johnson, L. A., & Sun, R. C. (2018) · Cells · doi:10.3390/cells7120229 · Cited by 67
Lipoprotein modifications by gingipains of Porphyromonas gingivalis
Lönn, J., Ljunggren, S., Klarström-Engström, K., Demirel, I., Bengtsson, T., & Karlsson, H. (2018) · Journal of Periodontal Research · doi:10.1111/jre.12527 · Cited by 63
Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
Wolska, A. T., Reimund, M., Sviridov, D. O., Amar, M. J., & Remaley, A. T. (2021) · Cells · doi:10.3390/cells10030597 · Cited by 64
[Metabolic difference between visceral fat and subcutaneous abdominal fat].
Björntorp, P. A. (2000) · PubMed · Cited by 60
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
Ramms, B., Patel, S., Nora, C., Pessentheiner, A. R., Chang, M. W., Green, C. R., Golden, G. J., Secrest, P., Krauss, R. M., Metallo, C. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093740 · Cited by 59
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: a genetic and proteomic multi-cohort study
Picard, C., Poirier, A., Bélanger, S., Labonté, A., Auld, D., Poirier, J., & on behalf of the PREVENT-AD Research Group (2019) · PLOS ONE · doi:10.1371/journal.pone.0220254 · Cited by 59
Mendelian randomization while jointly modeling cis genetics identifies causal relationships between gene expression and lipids
van der Graaf, A., Claringbould, A., Rimbert, A., Heijmans, B. T., Hoen, P. A. C. ’., van Meurs, J. B. J., Jansen, R., Franke, L., Westra, H.-J., Li, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18716-x · Cited by 58
Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry
Chetty, P. S., Mayne, L., Lund-Katz, S., Englander, S. W., & Phillips, M. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617523114 · Cited by 58
Self-citation
On-column trypsin digestion coupled with LC-MS/MS for quantification of apolipoproteins
Toth, C. A., Kuklenyik, Z., Jones, J. I., Parks, B. A., Gardner, M. S., Schieltz, D. M., Rees, J. C., Andrews, M., McWilliams, L. G., Pirkle, J. L., et al. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.09.011 · Cited by 56
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Emamzadeh, F. N. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0942-9 · Cited by 54
Recognition of lipoproteins by scavenger receptor class A members
Cheng, C., Zheng, E., Yu, B., Zhang, Z., Wang, Y., Liu, Y., & He, Y. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100948 · Cited by 56
Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease
Salameh, T. S., Rhea, E. M., Banks, W. A., & Hanson, A. J. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216660770 · Cited by 51
The effect of apolipoprotein E polymorphism on serum metabolome – a population-based 10-year follow-up study
Karjalainen, J.-P., Mononen, N., Hutri-Kähönen, N., Lehtimäki, M., Juonala, M., Ala-Korpela, M., Kähönen, M., Raitakari, O., & Lehtimäki, T. (2019) · Scientific Reports · doi:10.1038/s41598-018-36450-9 · Cited by 55
Interactions between Apolipoprotein E Metabolism and Retinal Inflammation in Age-Related Macular Degeneration
Hu, M. L., Quinn, J., & Xue, K. (2021) · Life · doi:10.3390/life11070635 · Cited by 51
From beta amyloid to altered proteostasis in Alzheimer’s disease
Bruni, A. C., Bernardi, L., & Gabelli, C. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101126 · Cited by 47
Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
Campos‐Peña, V., Pichardo-Rojas, P. S., Sánchez-Barbosa, T., Ortíz-Islas, E., Rodríguez-Pérez, C. E., Montes, P., Ramos-Palacios, G., Silva‐Adaya, D., Quintana, R. V., Cerna-Cortés, J. F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012092 · Cited by 47
Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer’s disease
Giannisis, A., Al-Grety, A., Carlsson, H., Patra, K., Twohig, D., Sando, S. B., Lauridsen, C., Berge, G., Grøntvedt, G. R., Bråthen, G., et al. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01058-9 · Cited by 46
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study
Blanchard, V., Ramin-Mangata, S., Billon-Crossouard, S., Aguesse, A., Durand, M., Chemello, K., Nativel, B., Flet, L., Chétiveaux, M., Jacobi, D., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p083576 · Cited by 43
Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease
Sfyri, P., & Matsakas, A. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0346-8 · Cited by 44
New evidence from plasma ceramides links apoE polymorphism to greater risk of coronary artery disease in Finnish adults
Karjalainen, J.-P., Mononen, N., Hutri‐Kähönen, N., Lehtimäki, M., Hilvo, M., Kauhanen, D., Juonala, M., Viikari, J. S. A., Kähönen, M. A. P., Raitakari, O. T., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m092809 · Cited by 43
The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity
Wen, Y., Chen, Y., & Konrad, R. J. (2022) · Advanced Biology · doi:10.1002/adbi.202200093 · Cited by 43
Association between apolipoprotein E polymorphisms and premature coronary artery disease: a meta-analysis
Zhao, Q., Yu, L., Li, J., Jiang, N., & Shi, J. P. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0145 · Cited by 40
Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection
Yang, Z., Wang, X., Chi, X., Zhao, F., Guo, J., Ma, P., Zhong, J., Niu, J., Pan, X., & Long, G. (2016) · Journal of Virology · doi:10.1128/jvi.01353-16 · Cited by 41
Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease
Dittrich, J., Beutner, F., Teren, A., Thiery, J., Burkhardt, R., Scholz, M. R., & Ceglarek, U. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.11.006 · Cited by 41
Genetics of Spontaneous Intracerebral Hemorrhage
Falcone, G. J., & Woo, D. (2017) · Stroke · doi:10.1161/strokeaha.117.017072 · Cited by 43
Multi-functional role of apolipoprotein E in neurodegenerative diseases
Islam, S., Noorani, A. A., Sun, Y., Michikawa, M., & Zou, K. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1535280 · Cited by 43
High‐affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid‐β
Ghosh, S., Sil, T. B., Dolai, S., & Garai, K. (2019) · FEBS Journal · doi:10.1111/febs.14988 · Cited by 40
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease
Talebi, M., Kakouri, E., Talebi, M., Tarantilis, P. Α., Farkhondeh, T., İlgün, S., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1923479 · Cited by 41
Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte‐derived lipid transport
Mok, K. K., Yeung, S. H., Cheng, G. W., Ma, I. W., Lee, R. H., Herrup, K., & Tse, K. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15748 · Cited by 37
Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline
Nock, T. G., Chouinard‐Watkins, R., & Plourde, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.004 · Cited by 37
Association of Apolipoprotein E gene polymorphism with the risk of T2DM and obesity among Egyptian subjects
Galal, A., Elmajeed, A. A. A., Elbaz, R., Wafa, A. M., & Elshazli, R. M. (2020) · Gene · doi:10.1016/j.gene.2020.145223 · Cited by 38
Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β
Chai, A. B., Lam, H. H. J., Kockx, M., & Gelissen, I. C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158980 · Cited by 41
Comparative analysis of effects of dietary arachidonic acid and EPA on growth, tissue fatty acid composition, antioxidant response and lipid metabolism in juvenile grass carp,Ctenopharyngodon idellus
Tian, J., Lei, C., Ji, H., Kaneko, G., Zhou, J., Yu, H., Li, Y., Yu, E., & Xie, J. (2017) · British Journal Of Nutrition · doi:10.1017/s000711451700215x · Cited by 37
APOE and immunity: Research highlights
Kloske, C. M., Barnum, C. J., Batista, A. F., Bradshaw, E. M., Brickman, A. M., Bu, G., Dennison, J. L., Gearon, M. D., Goate, A., Haass, C., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13020 · Cited by 38
The association of APOE genotype with COVID-19 disease severity
Lord, J. S., Rezaiezadeh, J. S., Yekaninejad, M. S., & Izadi, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-17262-4 · Cited by 35
Chronic exposure to chlorpyrifos triggered body weight increase and memory impairment depending on human apoE polymorphisms in a targeted replacement mouse model
Peris‐Sampedro, F., Basaure, P., Reverte, I., Cabré, M., Domingo, J. L., & Colomina, M. T. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.03.006 · Cited by 34
The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models
Centner, A. M., Khalili, L., Ukhanov, V., Kadyan, S., Nagpal, R., & Salazar, G. (2023) · Nutrients · doi:10.3390/nu15051212 · Cited by 32
Etiological relationship between lipid metabolism and endometrial carcinoma
Li, W., Xu, Y., Zeng, X., Tan, J., Wang, Y., Wu, H., Li, M., & Yi, C. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01868-2 · Cited by 33
Targeted Intracellular Delivery of Resveratrol to Glioblastoma Cells Using Apolipoprotein E-Containing Reconstituted HDL as a Nanovehicle
Kim, S. H., Adhikari, B. B., Cruz, S., Schramm, M. P., Vinson, J. A., & Narayanaswami, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135130 · Cited by 33
APOE Polymorphism is Associated with Blood Lipid and Serum uric Acid Metabolism in Hypertension or Coronary Heart Disease in a Chinese Population
Wang, C., Yan, W., Wang, H., Zhu, J., & Chen, H. (2019) · Pharmacogenomics · doi:10.2217/pgs-2019-0048 · Cited by 35
Dysbetalipoproteinemia
MARAIS, D. P. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000192 · Cited by 33
APOE and metabolic dysfunction in Alzheimer's disease
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.002 · Cited by 31
The ApoE ε4 Isoform: Can the Risk of Diseases be Reduced by Environmental Factors?
Bos, M. M., Noordam, R., Blauw, G. J., Slagboom, P. E., Rensen, P. C. N., & van Heemst, D. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly226 · Cited by 32
Multidimensional regulation of lipoprotein lipase: impact on biochemical and cardiovascular phenotypes
Hegele, R. A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.c070946 · Cited by 31
Identification and action mechanism of lipid regulating components from Rhei Radix et rhizoma
Wang, Y., Zhang, J., Xu, Z. Q., Zhang, G., Lv, H., Wang, X., Xu, G., Li, X., Yang, Z., Wang, H., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115179 · Cited by 30
Stem Cell Transcription Factor FoxO Controls Microbiome Resilience in Hydra
Mortzfeld, B. M., Taubenheim, J., Fraune, S., Klimovich, A. V., & Bosch, T. C. G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00629 · Cited by 33
PCSK9: A potential regulator of apoE/apoER2 against inflammation in atherosclerosis?
Bai, X.-Q., Peng, J., Wang, M., Xiao, J. H., Xiang, Q., Ren, Z., Wen, H.-Y., Jiang, Z., Tang, Z., & Liu, L. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.04.040 · Cited by 32
Advances in quantifying apolipoproteins using LC-MS/MS technology: implications for the clinic
van den Broek, I., Sobhani, K., & Eyk, J. E. V. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1374859 · Cited by 30
Human apolipoprotein E as a reservoir of cryptic bioactive peptides: The case of ApoE 133‐167
Zanfardino, A., Bosso, A., Gallo, G., Pistorio, V., Napoli, M. D., Gaglione, R., Dell’Olmo, E., Varcamonti, M., Notomista, E., Arciello, A., et al. (2018) · Journal of Peptide Science · doi:10.1002/psc.3095 · Cited by 29
HDL abnormalities in type 2 diabetes: Clinical implications
Martagón, A. J., Zubirán, R., González-Arellanes, R., Praget-Bracamontes, S., Rivera-Alcántara, J. A., & Aguilar-Salinas, C. A. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117213 · Cited by 30
Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner
Dratva, M. A., Banks, S. J., Panizzon, M. S., Galasko, D. R., Sundermann, E. E., & Initiative, A. D. N. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00620-4 · Cited by 30
Gender difference of metabolic syndrome and its association with dietary diversity at different ages
Tian, X., Xu, X., Zhang, K., & Wang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20625 · Cited by 28
The influence of ApoE4 on the clinical outcomes and pathophysiology of degenerative cervical myelopathy
Desimone, A. M. L., Hong, J., Brockie, S. T., Yu, W., Laliberté, A. M., & Fehlings, M. G. (2021) · JCI Insight · doi:10.1172/jci.insight.149227 · Cited by 29
Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy
González-Aldaco, K., Torres-Reyes, L. A., Ojeda‐Granados, C., José-Ábrego, A., Fierro, N. A., & Román, S. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.7191 · Cited by 27
The Role of ApoE in HCV Infection and Comorbidity
Gong, Y., & Cun, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082037 · Cited by 29
Plasma ApoE elevations are associated with NAFLD: The PREVEND Study
van den Berg, E. H., Corsetti, J. P., Bakker, S. J. L., & Dullaart, R. P. F. (2019) · PLOS ONE · doi:10.1371/journal.pone.0220659 · Cited by 27
Age and sex specific effects of APOE genotypes on ischemic heart disease and its risk factors in the UK Biobank
Li, M., Zhao, J. V., Kwok, M. K., & Schooling, C. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-88256-x · Cited by 26
Antibacterial and Anti-Inflammatory Effects of Apolipoprotein E
Puthia, M., Marzinek, J. K., Petruk, G., Ertürk, G., Bond, P. J., & Petrlová, J. (2022) · Biomedicines · doi:10.3390/biomedicines10061430 · Cited by 27
Apolipoprotein E-ε2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study
Toribio‐Fernández, R., Tristão‐Pereira, C., Silla-Castro, J. C., Callejas, S., Oliva, B., Fernandez‐Nueda, I., García‐Lunar, I., Pérez-Herreras, C., Ordovás, J. M., Martı́n, P., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323921 · Cited by 27
Drugs targeting APOE4 that regulate beta‐amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease
Poblano, J., Castillo‐Tobías, I., Berlanga, L., Tamayo‐Ordoñez, M. C., Rodríguez‐Salazar, M. D. C., Silva‐Belmares, S. Y., Aguayo‐Morales, H., & Cobos-Puc, L. E. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.14055 · Cited by 29
Genetics and Epigenetics of Spontaneous Intracerebral Hemorrhage
Steinhauer, E. G., Jiménez-Baladó, J., Pérez, I. F., Rey-Álvarez, L., Rodríguez-Campello, A., Ois, Á., Cuadrado‐Godia, E., Jiménez-Conde, J., & Roquer, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126479 · Cited by 26
Melatonin Suppresses Macrophage M1 Polarization and ROS‐Mediated Pyroptosis via Activating ApoE/LDLR Pathway in Influenza A‐Induced Acute Lung Injury
Xu, M., Kang, J., Ji, S., Wei, Y., Wei, S.-L., Ye, J.-J., Wang, Y., Shen, J., Wu, H., & Fei, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2520348 · Cited by 26
Apolipoprotein E Mimetic Peptide Increases Cerebral Glucose Uptake by Reducing Blood–Brain Barrier Disruption after Controlled Cortical Impact in Mice: An 18 F-Fluorodeoxyglucose PET/CT Study
Qin, X., You, H., Cao, F., Wu, Y., Peng, J., Pang, J., Xu, H., Chen, Y., Chen, L., Vitek, M. P., et al. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4485 · Cited by 26
AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in alzheimer's disease mice
Günaydin, C., Sondhi, D., Kaminsky, S. M., Lephart, H. C., Leopold, P. L., Hackett, N. R., Khanna, R., & Crystal, R. G. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.11.003 · Cited by 26
Apolipoprotein E2 and E3, but Not E4, Promote Retinal Pathologic Neovascularization
Masuda, T., Shimazawa, M., Hashimoto, Y., Kojima, A., Nakamura, S., Suemori, S., Mochizuki, K., Kawakami, H., Kawase, K., & Hara, H. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20539 · Cited by 25
Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis
Whitacre, B. E., Howles, P. N., Street, S. E., Morris, J. C., Swertfeger, D. K., & Davidson, W. S. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100157 · Cited by 25
Dissecting the Association of Apolipoprotein E Gene Polymorphisms With Type 2 Diabetes Mellitus and Coronary Artery Disease
Wu, L., Zhang, Y., Zhao, H., Rong, G., Huang, P., Wang, F., & Xu, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838547 · Cited by 25
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
Turri, M., Conti, E., Pavanello, C., Gastoldi, F., Palumbo, M., Bernini, F., Aprea, V., Re, F., Barbiroli, A., Emide, D., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01241-6 · Cited by 27
Interaction of serum proteins with SARS-CoV-2 RBD
Yin, Y., Sheng, Y.-J., Wang, M., Ma, Y., & Ding, H. (2021) · Nanoscale · doi:10.1039/d1nr02687a · Cited by 22
Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference
Butler, A. A., Price, C. A., Graham, J. L., Stanhope, K. L., King, S. M., Hung, Y.-H., Sethupathy, P., Wong, S. C., Hamilton, J., Krauss, R. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m089508 · Cited by 25
Role of apolipoprotein E in electronegative low-density lipoprotein-induced mitochondrial dysfunction in cardiomyocytes
Chen, W., Chen, Y.-F., Chan, H., Chung, C., Peng, H., Ho, Y., Chen, C., Chang, K., Tang, C., & Lee, A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154227 · Cited by 24
Physical Exercise Counteracts Aging-Associated White Matter Demyelination Causing Cognitive Decline
Butt, T. H., Tobiume, M., Ré, D. B., & Kariya, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0216 · Cited by 25

Authors: Phillips, M. C.
Affiliations: University of Pennsylvania (US)
Corresponding author: Phillips, Michael C.
ORCID: Phillips, Michael C.
Venue: IUBMB Life
Publisher: Wiley
Published: 2014-09
Volume: 66
Issue: 9
Pages: 616-623
ISSN: 1521-6543 (ISSN-L)
1521-6551
DOI: 10.1002/iub.1314
OpenAlex: W1841798962
Cited by: 328
References: 59
Citations by year: 2026: 20 · 2025: 25 · 2024: 41 · 2023: 35 · 2022: 36 · 2021: 38 · 2020: 27 · 2019: 27 · 2018: 24 · 2017: 23 · 2016: 22 · 2015: 8
FWCI: 2.85
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 49 d)
Locations: IUBMB Life (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: apolipoprotein E, apolipoprotein E isoforms, apolipoprotein E2, apolipoprotein E3, APOE ε4, lipoprotein metabolism, LDL receptor binding, type III hyperlipoproteinemia, dyslipidemia, VLDL cholesterol, protein structure, lipid binding, genetic polymorphism
MeSH terms: Apolipoproteins E, Humans, Lipoproteins, Models, Molecular, Protein Binding, Amino Acid Substitution, Protein Isoforms, Lipid Metabolism Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Apolipoprotein E isoforms and lipoprotein metabolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks